Patients with a variety of advanced cancers occurring in different sites of the body have trialed a larotrectinib, with three-quarters of patients, both adults, and children responding to the drug.
Scientists at the UNC School of Medicine and NC State have created an injectable gel-like scaffold that can hold combination chemo-immunotherapeutic drugs and deliver them locally to tumours in a sequential manner.
AstraZeneca has secured approval for one of its key new lung cancer drugs, cementing the medicine’s potential to become a blockbuster treatment.
There are wide differences in BRCA testing protocols at labs around the world. A new article surveyed 86 laboratories about their BRCA testing practices and found that all the labs differed widely in their approach.
Light-activated cancer drugs that don’t cause the toxic side effects of current chemotherapy treatments are closer to becoming a reality, a new study suggests.
The Food and Drug Administration (FDA) has been busy this week. Their most recent approval is for Johnson & Johnson’s Erleada for use in prostate cancer patients whose disease has not spread but continues to grow despite hormone therapy.
Conductive wires of DNA enhanced with gold which could be used to electrically measure hundreds of biological processes simultaneously.
Scientists have been able to show that tiny autonomous bots have the potential to function as intelligent delivery vehicles to cure cancer in mice.